Randy Brenner
Advertisement
Chief development and regulatory officer at Paratek.
Articles by Randy Brenner
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contagion Live
1
Single-Tablet Regimen of Bictegravir and Lenacapavir for HIV Meets Primary Endpoint in Phase 3 Study
2
Zoliflodacin Emerges as a First-in-Class Oral Option Against Drug-Resistant Gonorrhea
3
Caring Holistically: NYU’s Approach to Pediatric Infectious Disease
4
FDA Approves Zoliflodacin for Uncomplicated Urogenital Gonorrhea
5
